Abstract
Myasthenia gravis is a disorder of impaired neuromuscular transmission resulting in weakness and abnormal fatigability on exertion, improved by anti-acetyl cholinesterase drugs. A number of drugs are known to exacerbate myasthenia gravis or interfere with neuromuscular transmission. We report a case of D-penicillamine induced myasthenia gravis who developed ptosis, diplopia and easy fatigability, 4 years after initiation of the drug for Wilson’s disease. On stopping the drug, within 3 months all her symptoms disappeared without any anti-acetyl cholinesterase drugs. Thus, the onset of drug induced myasthenia gravis could be insidious but the withdrawal of the drug leads to rapid recovery.
Article Type
Case Report
First Page
293
Last Page
295
Recommended Citation
Varghese, Thomas; Ahmed, Riaz; Sankaran, Jayaram D.; and Al-Khusaiby, Saleh M.
(2002)
"D-Penicillamine induced myasthenia gravis,"
Neurosciences: Vol. 7:
Iss.
4, Article 12.
DOI: https://doi.org/10.17712/1658-3183.1174